Showing 101-110 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| New lipid biomarker to predict early risk for Type 1 diabetes | Beth Israel Deaconess Medical Center Inc | Barbara Kahn | Cures | 01-September-2024 to 31-August-2027 | $899.997,53 |
| University of Michigan and OHSU Breakthrough T1D Cardio-Renal Center of Excellence : Accelerating Breakthrough Targeted New Therapies for Cardio-Renal Complications for People with T1D | Regents of the University of Michigan | Matthias Kretzler | Improving Lives | 01-May-2025 to 30-April-2028 | $2.842.434,27 |
| Advanced CGM analyses for longitudinal monitoring of early-stage Type 1 Diabetes | Regents of the University of Colorado | Andrea Steck | Cures | 01-October-2024 to 30-September-2027 | $900.000,00 |
| CGM-Derived Glucose Dynamic Index as Diagnostic Marker for Progression to Type 1 Diabetes | Trustees of Indiana University | Viral Shah | Cures | 01-November-2024 to 31-October-2027 | $900.000,00 |
| Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy | Trustees of the University of Pennsylvania | Michael Betts | Cures | 01-September-2024 to 31-August-2027 | $900.000,00 |
| S1P transport inhibitors for prevention of T1D | Rector & Visitors of the University of Virginia | Kevin Lynch | Cures | 01-October-2024 to 30-September-2026 | $520.627,00 |
| REGULATORY ROLE OF CADM1 DURING AUTOIMMUNE DIABETES | Johns Hopkins University | Matthew Poy | Cures | 01-December-2024 to 30-November-2027 | $900.000,00 |
| Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas | Icahn School of Medicine at Mount Sinai | Dirk Homann | Cures | 01-June-2024 to 31-May-2026 | $145.989,21 |
| Pancreatic Islet Transplantation for the Treatment of Type 1 Diabetes: In-Silico Developments to Support Clinical Advancements | Rector & Visitors of the University of Virginia | Chiara Fabris | Cures | 01-January-2025 to 31-December-2025 | $299.916,19 |
| Determining how frequent infections alter autoreactive T-cell fates and type 1 diabetes risk | Regents of the University of Minnesota | Zachary Shaheen | Cures | 01-June-2024 to 31-May-2025 | $199.890,00 |